These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 7583142)

  • 1. RNA processing. Wilms' tumour--the splicing connection?
    Lamond AI
    Curr Biol; 1995 Aug; 5(8):862-5. PubMed ID: 7583142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor.
    Liu JJ; Wang ZY; Deuel TF; Xu YH
    Biochem Biophys Res Commun; 1999 Jan; 254(1):197-9. PubMed ID: 9920757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wilms' tumour--a case of disrupted development.
    Miyagawa K; Kent J; Schedl A; van Heyningen V; Hastie ND
    J Cell Sci Suppl; 1994; 18():1-5. PubMed ID: 7883783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of native WT1 protein from frozen human kidney and Wilms' tumors.
    Iben S; Royer-Pokora B
    Oncogene; 1999 Apr; 18(15):2533-6. PubMed ID: 10229205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splicing of exon 5 in the WT1 gene is disrupted in Wilms' tumour.
    Simms LA; Algar EM; Smith PJ
    Eur J Cancer; 1995 Dec; 31A(13-14):2270-6. PubMed ID: 8652255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
    Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
    Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
    Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilms tumor and the WT1 gene.
    Lee SB; Haber DA
    Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Wilms' tumor genes.
    Hirose M
    J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilms' tumor and the WT1 gene.
    Hata J
    Contrib Nephrol; 1999; 128():62-74. PubMed ID: 10597378
    [No Abstract]   [Full Text] [Related]  

  • 12. RNA editing in the Wilms' tumor susceptibility gene, WT1.
    Sharma PM; Bowman M; Madden SL; Rauscher FJ; Sukumar S
    Genes Dev; 1994 Mar; 8(6):720-31. PubMed ID: 7926762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple roles for the Wilms' tumour suppressor gene, WT1 in genitourinary development.
    Schedl A; Hastie N
    Mol Cell Endocrinol; 1998 May; 140(1-2):65-9. PubMed ID: 9722170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overlapping RNA and DNA binding domains of the wt1 tumor suppressor gene product.
    Bardeesy N; Pelletier J
    Nucleic Acids Res; 1998 Apr; 26(7):1784-92. PubMed ID: 9512553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of WTAP, a novel Wilms' tumour 1-associating protein.
    Little NA; Hastie ND; Davies RC
    Hum Mol Genet; 2000 Sep; 9(15):2231-9. PubMed ID: 11001926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygous intragenic deletion in the WT1 gene in a sporadic Wilms' tumour associated with high levels of expression of a truncated transcript.
    Algar EM; Kenney MT; Simms LA; Smith SI; Kida Y; Smith PJ
    Hum Mutat; 1995; 5(3):221-7. PubMed ID: 7599632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells.
    Menke AL; Riteco N; van Ham RC; de Bruyne C; Rauscher FJ; van der Eb AJ; Jochemsen AG
    Oncogene; 1996 Feb; 12(3):537-46. PubMed ID: 8637710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1.
    Hewitt SM; Hamada S; McDonnell TJ; Rauscher FJ; Saunders GF
    Cancer Res; 1995 Nov; 55(22):5386-9. PubMed ID: 7585606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of WT1 function leads to ectopic myogenesis in Wilms' tumour.
    Miyagawa K; Kent J; Moore A; Charlieu JP; Little MH; Williamson KA; Kelsey A; Brown KW; Hassam S; Briner J; Hayashi Y; Hirai H; Yazaki Y; van Heyningen V; Hastie ND
    Nat Genet; 1998 Jan; 18(1):15-7. PubMed ID: 9425891
    [No Abstract]   [Full Text] [Related]  

  • 20. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
    Park S; Tomlinson G; Nisen P; Haber DA
    Cancer Res; 1993 Oct; 53(20):4757-60. PubMed ID: 8402654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.